Search for a command to run...
<ns3:p>Background. In recent years, a dynamic increase in the use of robotic systems in colorectal surgery has been observed. One of the newer solutions is the modular Versius robotic system, whose safety and effectiveness are currently being intensively evaluated in routine clinical practice.Aim of the study. To assess the safety and feasibility of procedures performed with the Versius robotic system in colorectal cancer surgery based on more than two years of single-center experience.Materials and methods. A retrospective analysis was conducted of patients who underwent surgery for colorectal cancer at a single oncological center using the Versius robotic system between December 5, 2022 and August 27, 2025. The analysis included selected clinical and demographic characteristics, type of procedure, operative time (skin-to-skin), console time, blood loss, conversions to laparotomy, intra- and postoperative complications classified according to the Clavien–Dindo scale, reoperations, 30-day readmissions and mortality, length of hospital stay, and oncological parameters (resection radicality, number of retrieved lymph nodes, and completeness of the mesorectum).Results. The study included 191 patients (51.8% men; mean age 69.79.8 years). The majority of patients were classified as ASA class II–III. The most frequently performed procedures were anterior resection of the rectum (41.4%), right hemicolectomy (26.7%), and sigmoid resection (13.6%). The median skin-to-skin operative time was 225 min [IQR 185–269], and the median length of hospital stay was 6 days [IQR 5–7]. Conversion to laparotomy was required in 8 patients (4.2%). Postoperative complications occurred in 40 patients (20.9%), including minor complications (Clavien–Dindo I–II) in 26 (13.6%) and major complications (Clavien–Dindo ≥III) in 14 patients (7.3%). One perioperative death was recorded (0.5%). Reoperation was required in 13 patients (6.8%), and 30-day readmission occurred in 6 patients (3.1%). The median number of retrieved lymph nodes was 22 [IQR 14–25], and at least 12 lymph nodes were retrieved in 87.9% of patients. Among patients with rectal cancer, the rate of specimens with complete mesorectal excision was 75.3%.Conclusions. The Versius robotic system is a safe tool in colorectal cancer surgery. The low conversion rate, acceptable complication profile, and adequate lymph node yield indicate that the system can be effectively implemented in the routine practice of a colorectal surgery center.</ns3:p>